Papillary carcinoma of the thyroid: Evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis

Journal of Pathology

Volumn 199, Issue 2, 2003, Pages 243-250

  Scarpino, Stefania ^a   Cancellario d'Alena, Francesca ^a   Di Napoli, Arianna ^a   Ballarini, Francesca ^a   Prat, Maria ^b   Ruco, Luigi P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Angiogenesis; Endothelial cell nitric oxide synthase (EC NOS); Endothelial cell proliferation; Hepatocyte growth factor (HGF); Hepatocyte growth factor receptor (HGF R); Met protein; Papillary thyroid carcinoma; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; MONOCLONAL ANTIBODY KI 67; NITRIC OXIDE SYNTHASE; RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; VASCULOTROPIN; VASCULOTROPIN C; VON WILLEBRAND FACTOR;

ADULT; ANGIOGENESIS; ARTICLE; BINDING AFFINITY; BLOOD VESSEL; CANCER TISSUE; CAPILLARY; CARCINOMA CELL; CELL ACTIVATION; CELL LINE; CELL PROLIFERATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME SPECIFICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SUPERNATANT; THYROID PAPILLARY CARCINOMA; TISSUE SECTION; TUMOR CELL; TUMOR CELL CULTURE; TUMOR PROMOTION; TUMOR VASCULARIZATION;

ADULT; ANIMALS; CARCINOMA, PAPILLARY; CELL DIVISION; CELL LINE; CHEMOTACTIC FACTORS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE; RNA, NEOPLASM; THYROID NEOPLASMS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037314468     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1278     Document Type: Article

References (25)

1. Akslen LA, LiVolsi VA. Increased angiogenesis in papillary carcinoma but lack of prognostic importance. Hum Pathol 2000; 31: 439-442.
2. Katoh R, Hemmi A, Komiyama A, Kawaoi A. Confocal laser scanning microscopic observation of angioarchitectures in human thyroid neoplasm. Hum Pathol 1999; 30: 1226-1231.
3. Scarpino S, Stoppacciaro A, Pellegrini C, et al. Expression of EDA/EDB isoforms of fibronectin in papillary carcinoma of the thyroid. J Pathol 1999; 188: 163-167.
4. Viglietto G, Maglione D, Rambaldi M, et al. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PIGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 1995; 11: 1569-1579.
5. Katoh R, Miyagi E, Kawaoi A, et al. Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms. Hum Pathol 1999; 30: 891-897.
6. Bunone G, Vigneri P, Mariani L, et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 1999; 155: 1967-1976.
7. Moriyama T, Kataoka H, Hamasuna R, et al. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 1998; 249: 73-77.
8. Gherardi E, Soker M. Hepatocytes and scatter factor. Nature 1990; 346: 228.
9. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993; 123: 223-235.
10. Kobayashi T, Henke K, Miyazaki T, et al. Hepatocyte growth factor specifically binds to sulfoglycolipids. J Biol Chem 1994; 269: 9817-9821.
11. Prat M, Narsimhan R, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991; 49: 323-328.
12. Di Renzo MF, Narsimhan RP, Olivero M, et al. Expression of the met/HGF receptor in normal and neoplastic human tissues. Oncogene 1991; 6: 1997-2003.
13. Ruco LP, Ranalli T, Marzullo A, et al. Expression of Met protein in thyroid tumors. J Pathol 1996; 180: 266-270.
14. Naldini L, Tamagnone L, Vigna E, et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992; 11: 4825-4833.
15. Zanetti A, Stoppacciaro A, Marzullo A, et al. Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid. J Pathol 1998; 186: 287-291.
16. Dong QG, Bernasconi S, Lostaglio S, et al. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler Thromb Vasc Biol 1997; 17: 1599-1604.
17. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumours mediated by angiopoietins and VEGF. Science 1999; 284: 1994-1998.
18. Ziche M, Morbidelli L. Nitric oxide and angiogenesis. J Neurooncol 2000; 50: 139-148.
19. Mortensen K, Holck S, Christensen IJ, et al. Endothelial cell nitric oxide synthase in peritumoral microvessels is a favourable prognostic indicator in premenopausal breast cancer patients. Clin Cancer Res 1999; 5: 1093-1097.
20. Fox SB, Gatter KC, Harris AL. Tumour angiogenesis. J Pathol 1996; 179: 232-237.
21. Soh EY, Duh QY, Sobhi SA, et al. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid. J Clin Endocrinol Metab 1997; 82: 3741-3747.
22. Yancopoulos GD, Davis M, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-248.
23. Lennard CM, Patel A, Wilson J, et al. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery 2001; 129: 552-558.
24. Nicosia RF. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis? Am J Pathol 1998; 153: 11-16.
25. Ruco LP, Stoppacciaro A, Ballarini F, Prat M, Scarpino S. Met protein and hepatocyte, growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis. J Pathol 2001; 194: 4-8.